Mr. Korb has 15 years of investor relations, communications and financial advisory experience in the life science space. Over his career, Mr. Korb has worked closely with nearly 100 biotechnology, medical technology and specialty pharmaceutical companies. He has extensive experience advising companies and developing targeted investor relations initiatives, helping handle the many issues facing companies in this sector, including clinical data announcements, activist situations, regulatory issues, financings, management changes, partnerships, litigation and M&A activity. Through Trout Capital he has helped raise over $500M for public and private companies in the US and Europe through private placements, registered directs, convertible debt, royalty transactions and secondary offerings. He helped create and launch Trout’s popular US and EU Wall Street Unplugged Conference series as well as the Annual Hamptons CEO Roundtable. He previously worked as an Assistant Director for the California Public Interest Research Group, a non-profit environmental organization where he headed fundraising efforts in Southern California and attracted media coverage on target issues by drafting press releases and organizing news conferences.
He graduated magna cum laude from Tufts University with a Bachelor of Arts degree in psychology. He is an avid marathon runner and IRONMAN finisher, loves to travel and maintains his focus through regular yoga practice. He also holds Series 7, 79 and 63 securities licenses.